CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 106 enrolled
Drug / intervention
Data collectionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02487472
NCT02487472N/ACompleted

Burden of Herpes Zoster and Post-herpetic Neuralgia Among People ≥ 50 Years Old in France: the POSTHER Study

GlaxoSmithKline·observational·Posted Jul 1, 2015·Updated Sep 4, 2019

In Brief

An observational study evaluating Data collection for Herpes Zoster. Completed, enrolled 106 participants.

Detailed Summary

The purpose of this study is to assess the burden of Herpes zoster (HZ) and post-herpetic neuralgia (PHN) among people ≥ 50 years old in France, in terms of healthcare resources used, medical direct and indirect costs, as well as pain severity and impact on quality of life.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHerpes Zoster
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 1, 2015
Enrollment StartJan 19, 2016
Primary CompletionAug 28, 2017
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 11.0 years ago

Interventions

Data collectionother

Data sheet, ZBPI questionnaire and EQ-5D 5L Health state questionnaire